Literature DB >> 7964644

Review: molecular biology of the hepatitis C virus.

L J van Doorn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7964644     DOI： 10.1002/jmv.1890430406

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


× No keyword cloud information.
  11 in total

1.  Recent advances in laboratory diagnosis of hepatitis C virus infection.

Authors:  R Chaudhary
Journal:  Can J Infect Dis       Date:  1994-11

2.  Predominance of hepatitis C virus genotype 1b in Bulgaria.

Authors:  A Andonov; P Teoharov; S Bakalova
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

Review 3.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

4.  Detection of anti-hepatitis C-virus antibodies and hepatitis C-virus RNA in Lebanese hemodialysis patients.

Authors:  G E Abdelnour; G M Matar; H M Sharara; A M Abdelnoor
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

5.  Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase.

Authors:  P Borowski; K Oehlmann; M Heiland; R Laufs
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Effects of COX-2 inhibitor NS-398 on IL-10 expression in rat fungal keratitis.

Authors:  Na Li; Cheng-Ye Che; Li-Ting Hu; Jing Lin; Qing Wang; Gui-Qiu Zhao
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

7.  Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.

Authors:  A Meola; A Sbardellati; B Bruni Ercole; M Cerretani; M Pezzanera; A Ceccacci; A Vitelli; S Levy; A Nicosia; C Traboni; J McKeating; E Scarselli
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Genotyping of hepatitis C virus isolates from Basque Country, Spain.

Authors:  G Cilla; M García-Bengoechea; E Perez-Trallero; I Montalvo; D Vicente; J I Arenas
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

Review 9.  Recent Advances in Development of DNA Vaccines Against Hepatitis C virus.

Authors:  Sami Ullah; Muhammad Ali A Shah; Nosheen Riaz
Journal:  Indian J Virol       Date:  2012-03-20

10.  The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus.

Authors:  Zhengbin Zhang; Dylan Harris; Virendra N Pandey
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.